Neurocysticercosis: diagnosis via metagenomic next-generation sequencing.


Journal

Practical neurology
ISSN: 1474-7766
Titre abrégé: Pract Neurol
Pays: England
ID NLM: 101130961

Informations de publication

Date de publication:
23 Nov 2023
Historique:
accepted: 20 06 2023
medline: 27 11 2023
pubmed: 20 7 2023
entrez: 19 7 2023
Statut: epublish

Résumé

A 68-year-old Brazilian woman had 3 months of progressive fatigue, difficulty walking and 18 kg weight loss. On examination, there was gait apraxia and executive dysfunction. MR scan of brain showed communicating hydrocephalus and a cerebrospinal fluid showed 105 white cells/µL (≤5), predominantly lymphocytes, protein of 1.35 g/L (0.15-0.45) and the glucose content of 0.06 mmol/L (3.3-4.4). We suspected an infective cause and used of metagenomic next-generation sequencing to diagnose neurocysticercosis. This case highlights the challenge of diagnosing chronic meningitis and the relevance of genetic approaches in diagnosing neurological infections.

Identifiants

pubmed: 37468299
pii: pn-2023-003795
doi: 10.1136/pn-2023-003795
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

509-511

Informations de copyright

© Author(s) (or their employer(s)) 2023. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Denison Alves Pedrosa (DA)

General Neurology Division, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil.

Gustavo Bruniera Peres Fernandes (G)

Research and Development Sector, Clinical Laboratory, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil.

Luís Filipe de Souza Godoy (L)

Department of Radiology, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil.

André C Felício (A)

General Neurology Division, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil.

João Rebello Pinho (JR)

Research and Development Sector, Clinical Laboratory, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil.

André Mário Doi (A)

Research and Development Sector, Clinical Laboratory, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil.

René de Araújo Gleizer (R)

General Neurology Division, Albert Einstein Israeli Institute of Education and Research, São Paulo, Brazil rgleizer1986@gmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH